Company Filing History:
Years Active: 2017-2023
Title: Innovations by Inventor Ying Bao in Pharmaceutical Chemistry
Introduction
Ying Bao is an accomplished inventor based in Tianjin, China, recognized for his significant contributions to the field of pharmaceutical chemistry. With a total of five patents to his name, his work primarily focuses on improving the solubility and crystallization methods of pharmaceutical compounds.
Latest Patents
Among Ying Bao's latest inventions are two notable patents. The first patent details a **crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide with large particle size**. This invention showcases a triclinic crystal system that enhances the solubility and efficacy of this compound through an innovative crystallization method. The process involves mixing the solid with a solvent, heating it to dissolve completely, cooling the solution, and subsequently adding an anti-solvent to precipitate crystalline structures.
The second patent focuses on **etoricoxib solvates and their preparation method**. This discovery revolves around using specific hydrogen bond donor and acceptor solvents to form stable, concentrated etoricoxib solvates that improve the solubility and flowability of the drug. The resulting solvates demonstrate high thermal stability and can be prepared efficiently with a molar yield exceeding 90%.
Career Highlights
Ying Bao's career is marked by his collaborations with prominent institutions such as **Tianjin University** and **Hainan Lingkang Pharmaceutical Co., Ltd.**. His work in these institutions has enabled him to hone his research and development skills, leading to innovative breakthroughs in pharmaceutical formulations.
Collaborations
Throughout his career, Ying Bao has collaborated closely with esteemed colleagues including **Baohong Hou** and **Chuang Xie**. These partnerships have fostered an environment of scientific inquiry that has been instrumental in advancing their shared goals in pharmaceutical research.
Conclusion
Ying Bao exemplifies the spirit of innovation within the pharmaceutical industry. With a strong portfolio of patents that focus on enhancing drug solubility and crystallization methods, he continues to contribute significantly to the scientific community. His work not only benefits pharmaceutical applications but also exemplifies the potential impact of collaborative efforts in research and development.